Published in Acta Psychiatr Scand on August 24, 2008
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study. J Am Acad Child Adolesc Psychiatry (2015) 1.07
Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol (2011) 1.04
Controversies concerning the diagnosis and treatment of bipolar disorder in children. Child Adolesc Psychiatry Ment Health (2010) 1.03
Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. J Clin Psychopharmacol (2010) 0.89
Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service. BMC Psychiatry (2013) 0.84
Bipolar depression: clinically missed, pharmacologically mismanaged. Ther Adv Psychopharmacol (2011) 0.83
Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity. Int J Bipolar Disord (2013) 0.82
Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder. J Affect Disord (2010) 0.82
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. Int J Neuropsychopharmacol (2016) 0.82
Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord (2010) 0.81
The continuum of unipolar depression − bipolar II depression - bipolar I depression: different treatments indicated? World Psychiatry (2011) 0.78
Review: long term use of antidepressants for bipolar disorder reduces depressive episodes but increases risk of mania. Evid Based Ment Health (2009) 0.77
The presentation, recognition and management of bipolar depression in primary care. J Gen Intern Med (2013) 0.76
Expand the applicability and acceptability of CBT approaches in mood disorders. World Psychiatry (2014) 0.75
The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features. Curr Neuropharmacol (2017) 0.75
Long-term efficacy and safety of lamotrigine for all types of bipolar disorder. Neuropsychiatr Dis Treat (2017) 0.75
Athanasios Koukopoulos' Psychiatry: The Primacy of Mania and the Limits of Antidepressants. Curr Neuropharmacol (2017) 0.75
Ten ways to improve the treatment of depression and anxiety in adults. Ment Health Fam Med (2013) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med (2008) 19.86
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry (2002) 6.99
Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry (2004) 4.72
Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care (1996) 3.37
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry (2003) 3.14
Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord (2006) 2.74
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry (2003) 2.69
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry (2005) 2.59
Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA (2006) 2.53
What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry (2004) 2.43
Antidepressants in bipolar disorder: the case for caution. Bipolar Disord (2003) 2.27
Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry (1994) 1.96
Strategies to reduce misdiagnosis of bipolar depression. Psychiatr Serv (2001) 1.93
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry (2003) 1.84
Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord (1999) 1.82
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry (2003) 1.72
Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry (1998) 1.60
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv (2007) 1.48
Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43
An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clin Epidemiol (2006) 1.31
Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry (1988) 1.25
A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders. Bipolar Disord (2004) 1.25
Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry (2002) 1.22
Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry (2001) 1.22
Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry (1973) 1.21
Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry (1998) 1.12
Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry (1984) 1.10
Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord (2007) 1.08
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry (2001) 1.04
Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol (2005) 1.00
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci (2000) 0.98
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord (2001) 0.96
Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry (1982) 0.95
Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol (1993) 0.91
Lithium and suicidal risk. Bipolar Disord (2008) 0.85
Strategies for preventing the recurrence of bipolar disorder. J Clin Psychiatry (2004) 0.85
Management of the depressive component of bipolar disorder. Depress Anxiety (1997) 0.84
Risk of mania with antidepressants. Arch Pediatr Adolesc Med (2005) 0.83
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci (2005) 0.81
Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiatry (1981) 0.80
Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. J Affect Disord (1990) 0.78
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand (2001) 2.42
False neurotransmitters and hepatic failure. Lancet (1971) 2.34
Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry (1989) 2.07
Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand (2007) 1.87
Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry (2000) 1.71
Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int J Dev Neurosci (2000) 1.71
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry (2000) 1.66
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry (1997) 1.61
Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry (1998) 1.60
The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry (1983) 1.60
Comorbid substance-use in schizophrenia: relation to positive and negative symptoms. Schizophr Res (2006) 1.57
Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand (2003) 1.52
Lithium salts: 1970-1975. Ann Intern Med (1975) 1.48
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry (1994) 1.45
The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro. J Pharmacol Exp Ther (1967) 1.44
Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry (1980) 1.43
Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry (1992) 1.43
Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality. Acta Psychiatr Scand (2005) 1.41
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. J Am Acad Child Adolesc Psychiatry (1993) 1.39
Conversions from clozapine to other antipsychotic drugs. Arch Gen Psychiatry (1995) 1.39
Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. Arch Gen Psychiatry (1994) 1.39
Severe daytime somnolence in patients treated with an MAOI. Am J Psychiatry (1988) 1.38
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry (2000) 1.28
Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression. Arch Gen Psychiatry (1993) 1.24
Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry (2001) 1.22
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry (1975) 1.20
Pharmacologically induced behavioural supersensitivity to apomorphine. Nat New Biol (1973) 1.19
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry (1997) 1.18
Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. Am J Psychiatry (1988) 1.16
Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry (1998) 1.14
Effects of lithium and of pH on synaptosomal metabolism of noradrenaline. Nature (1970) 1.14
Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry (1998) 1.14
Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev Neurosci (1999) 1.13
Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry (1998) 1.12
Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand (2009) 1.11
Risks and implications of interrupting maintenance psychotropic drug therapy. Psychother Psychosom (1995) 1.11
The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry (1985) 1.11
A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy. J Am Acad Child Adolesc Psychiatry (1989) 1.10
Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology (1973) 1.10
Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry (1999) 1.09
Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neurosci Lett (1998) 1.09
Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology (1991) 1.09
A sensitive and specific enzymatic isotopic assay for tissue histamine. J Pharmacol Exp Ther (1966) 1.08
Pathogenesis and therapy of hepatic coma. Prog Liver Dis (1976) 1.07
Factors associated with noncompliance with psychiatric outpatient visits. Psychiatr Serv (2001) 1.03
Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res Dev Brain Res (1998) 1.03
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry (1991) 1.02
Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors. Neuroscience (1998) 1.02
S-(+)-aporphines are not selective for human D3 dopamine receptors. Cell Mol Neurobiol (1994) 1.01
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. Am J Psychiatry (1996) 1.01
Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes (Lond) (2006) 1.01
Motor effects of serotonin in the central nervous system. Life Sci (1980) 1.00
Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP. Nature (1974) 1.00
Metabolism of norepinephrine in the central nervous system. Pharmacol Rev (1966) 1.00
Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology (1974) 0.99
Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harv Rev Psychiatry (1997) 0.99
Psychotic reactions during amitriptyline therapy. Can Psychiatr Assoc J (1968) 0.97
Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry (1996) 0.97
Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol (1994) 0.97
Fluoxetine and side effects. Arch Gen Psychiatry (1990) 0.96
Tritiated norepinephrine: release from brain slices by electrical stimulation. Science (1966) 0.96
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology (1993) 0.95
Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf (1996) 0.95
Effects of L-dopa on norepinephrine metabolism in the brain. Proc Natl Acad Sci U S A (1971) 0.95
Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci (1997) 0.95
(+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res (1991) 0.94
The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry (1977) 0.93
Clozapine in severe mood disorders. J Clin Psychiatry (1995) 0.93
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry (1993) 0.92
Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation. Nat New Biol (1973) 0.92
Formation of catechol compounds from phenylalanine and tyrosine with isolated nerve endings. Nat New Biol (1972) 0.92
Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther (2001) 0.92
Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatr Scand (2012) 0.92
Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity. J Med Chem (1993) 0.91
Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu Rev Neurosci (1980) 0.91
Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse (1998) 0.91
Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Brain Res Dev Brain Res (1989) 0.91
Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations. Arch Gen Psychiatry (1988) 0.90
Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues. J Med Chem (1990) 0.90
Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Acta Psychiatr Scand (2008) 0.90
What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatry Res (1980) 0.89
Tardive and withdrawal dyskinesia associated with haloperidol. Am J Psychiatry (1974) 0.88
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry (1995) 0.88
Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: a meta-analytic review. Pharmacopsychiatry (2010) 0.88
Dissimilar dosing with high-potency and low-potency neuroleptics. Am J Psychiatry (1984) 0.88
Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry (1999) 0.88
S-adenosylmethionine in brain and other tissues. J Neurochem (1966) 0.88
Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine. Eur J Pharmacol (1978) 0.87
Status of psychotropic drug blood level assays and other biochemical measurements in clinical practice. Am J Psychiatry (1979) 0.87
The uptake of (3H)dopamine by homogenates of rat corpus striatum: effects of cations. Life Sci (1973) 0.86
[3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue. Eur J Pharmacol (1999) 0.86
N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem (1996) 0.86
Delirium during clozapine treatment: incidence and associated risk factors. Pharmacopsychiatry (2003) 0.86
Tolerance to therapeutic effects of antidepressants. Am J Psychiatry (1985) 0.86
Calcium leakage as a cause of the high resting tension in vascular smooth muscle from the spontaneously hypertensive rat. Proc Natl Acad Sci U S A (1978) 0.86
Tardive dyskinesia: an evaluation of the etiologic association with neuroleptic therapy. Can Psychiatr Assoc J (1974) 0.85
Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Res (1997) 0.85